Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

IST/ONCSM stock hub

IST/ONCSM has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IST/ONCSMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

7.1B

Istanbul Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

IST/ONCSM

In the news

Latest news · IST/ONCSM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 13.7P50 15.1P75 15.3

Trailing P/E140.4

P25 16.6P50 25.2P75 56.6

ROE13.2

P25 -2.4P50 3.5P75 11.2

ROIC24.4

P25 -0.7P50 4.3P75 13.6

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IST/ONCSM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

188

Groups with data

Currency

TRY

Showing 188 of 188 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Turkey
Country code	TR
Employees	408
Employees Change	116%
Employees Change Percent	39.73
Enterprise value	TRY 7.1B
Exchange	Istanbul Stock Exchange
Financial currency	TRY
First seen	2026-05-10
Industry	Medical Devices
Isin	TREONCO00026
Last refreshed	2026-05-10
Market cap	TRY 7.1B
Price	TRY 297
Price currency	TRY
Rev Per Employee	1,737,934.04x
Sector	Healthcare
Sic	3841
Symbol	ist/ONCSM
Website	https://www.oncosem.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.71%
EV Earnings	141.27x
EV/EBIT	46.63x
EV/EBITDA	34.23x
EV/FCF	843.75x
EV/Sales	10.04x
FCF yield	0.12%
P/B ratio	17.39x
P/E ratio	140.44x
P/S ratio	9.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	21.53%
EBITDA Margin	29.33%
FCF margin	1.19%
Gross margin	45.11%
Gross Profit	TRY 319.8M
Gross Profit Growth	76.4%
Gross Profit Growth Q	229.72%
Gross Profit Growth3 Y	46.99%
Net Income	TRY 50.4M
Pretax Margin	10.35%
Profit Margin	7.11%
Profit Per Employee	TRY 123,514
ROA	16.96
ROCE	32.53
ROE	13.16
ROIC	24.44
Roic5y	18.08

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	236.16%
Cagr3y	69.79%
FCF Growth	-89.9%
FCF Growth Q	-80.42%
FCF Growth3 Y	-31.86%
OCF Growth	-38.14%
OCF Growth Q	-30.51%
OCF Growth3 Y	9.6%
Revenue Growth	44.66x
Revenue Growth Q	55.14x
Revenue Growth3 Y	34.27x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TRY 1.26
Assets	TRY 624.2M
Cash	TRY 45.4M
Current Assets	TRY 404.1M
Current Liabilities	TRY 154.8M
Debt	TRY 86.8M
Debt EBITDA	TRY 0.42
Debt Equity	TRY 0.21
Debt FCF	TRY 10.29
Equity	TRY 407M
Interest Coverage	4.73
Liabilities	TRY 217.2M
Long Term Assets	TRY 220.1M
Long Term Liabilities	TRY 62.3M
Net Cash	TRY -41.4M
Net Cash By Market Cap	TRY -0.59
Net Debt EBITDA	TRY 0.2
Net Debt Equity	TRY 0.1
Net Debt FCF	TRY 4.91
Tangible Book Value	TRY 403.1M
Tangible Book Value Per Share	TRY 16.9
WACC	8.63

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.61
Inventory Turnover	3.91
Net Working Capital	TRY 279.5M
Quick ratio	2
Working Capital	TRY 249.3M
Working Capital Turnover	TRY 3.31

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend per share	TRY 0
Last Dividend	TRY 0.41

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	235.88%
200-day SMA	222.2
3Y total return	389.69%
50-day SMA	262.6
50-day SMA vs 200-day SMA	50over200
All Time High	376
All Time High Change	-21.08%
All Time High Date	2026-01-20
All Time Low	19.25
All Time Low Change	1,441.56%
All Time Low Date	2023-01-04
ATR	16.29
Beta	0.76
Beta1y	1.17
Beta2y	0.68
Ch YTD	12.83
High	304.8
High52	376
High52 Date	2026-01-20
High52ch	-21.08%
Low	266.3
Low52	76
Low52 Date	2025-06-23
Low52ch	290.46%
Ma50ch	13.02%
Price vs 200-day SMA	33.54%
RSI	62.47
RSI Monthly	65.21
RSI Weekly	61.99
Sharpe ratio	2.33x
Sortino ratio	4.48
Tr YTD	12.83
Tr1m	11.35%
Tr1w	9.91%
Tr3m	2.06%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TRY 152.7M
Operating Income Growth	2,075.2
Operating Income Growth3 Y	66.6
Operating margin	21.53

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,395,000%
Net Borrowing	28,547,740
Shares Insiders	63.71%
Shares Institutions	1%
Shares Out	23,850,000
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TRY 8.4M
Average Volume	767,072.75x
Bv Per Share	17.07
CAPEX	TRY -60.9M
Ch1m	11.35
Ch1w	9.91
Ch1y	235.9
Ch3m	2.06
Ch3y	388.5
Ch6m	29.59
Change	4.86%
Change From Open	2.68
Close	283
Days Gap	2.12
Depreciation Amortization	55,336,028
Dollar Volume	954,533,765.5
Earnings Date	2026-05-12
EBIT	TRY 152.7M
EBITDA	TRY 208M
EPS	TRY 2.11
F Score	6
FCF	TRY 8.4M
FCF EV Yield	0.12x
FCF Per Share	TRY 0.35
Financing CF	-3,704,680
Fiscal Year End	December
Founded	2,008
Graham Number	28.48326
Graham Upside	-90.4
Income Tax	TRY 23M
Investing CF	-65,656,830
Is Primary Listing	1
Last Earnings Date	2026-02-18
Last Report Date	2025-12-31
Ma150	256.4
Ma150ch	15.76%
Ma20	281.9
Ma20ch	5.27%
Net CF	-13,082,457
Next Earnings Date	2026-05-12
Open	289
P FCF Ratio	838.8
P OCF Ratio	102
Position In Range	79.22
Ppne	191,968,087
Price Date	2026-05-08
Price EBITDA	TRY 34.03
Ptbv Ratio	17.56
Relative Volume	4.19x
Revenue	709,077,088x
Tax By Revenue	3.24x
Tax Rate	31.34%
Tr6m	29.59%
Volume	3,216,626
Z Score	11.28

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does IST/ONCSM pay a dividend?

Capital-return profile for this ticker.

Performance

IST/ONCSM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IST/ONCSM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.0%

Share of float held by funds and institutions

Insider ownership

+63.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

IST/ONCSM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

62.5

Neutral momentum band

Price vs 200-day MA

+33.5%

50/200-day relationship not available

Beta (5Y)

0.76

Less volatile than the market

Sharpe ratio

2.33

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IST/ONCSM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ist/ONCSM stock rating?

ist/ONCSM is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ist/ONCSM analysis?

The full report lives at /stocks/ist/ONCSM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ist/ONCSM?

The latest report frames ist/ONCSM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ist/ONCSM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.